- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
C4 Therapeutics Inc (CCCC)
Assess today's live C4 Therapeutics Inc (CCCC) share price, performance and insights using our live NASDAQ: CCCC stock exchange data.
Analyse the historical data and C4 Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on C4 share price buy/sell indicators using real-time data (or discuss the C4 (CCCC) stock price today with other investors in the C4 NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CCCC share price (ISIN: US12529R1077) to enhance your trading decisions with our free investment tools and resources.
What Is the C4 Therapeutics Inc Share Price Today?
The C4 share price today is 2.02.
What Is the Stock Symbol for C4 Therapeutics Inc
The stock symbol (or 'ticker') for C4 Therapeutics Inc is "CCCC."
What Stock Exchange Does C4 Therapeutics Inc Trade On?
C4 Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is C4 Therapeutics Inc a Good Stock to Buy?
Determining whether C4 Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and C4 Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on C4 share price buy/sell indicators using real-time data (or discuss the C4 (CCCC) stock price today with other investors in the C4 NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CCCC share price (ISIN: US12529R1077) to enhance your trading decisions with our free investment tools and resources.
What Is the C4 Therapeutics Inc Share Price Today?
The C4 share price today is 2.02.
What Is the Stock Symbol for C4 Therapeutics Inc
The stock symbol (or 'ticker') for C4 Therapeutics Inc is "CCCC."
What Stock Exchange Does C4 Therapeutics Inc Trade On?
C4 Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is C4 Therapeutics Inc a Good Stock to Buy?
Determining whether C4 Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.93
2.07
52 wk Range
1.09
4.26
CCCC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.932.07
52 wk Range
1.094.26
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CCCC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.14
Upside
+451.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
C4 Company Profile
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 clinical trials targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT1946, an orally bioavailable BiDAC degrader targeting BRAF V600 mutant that is in Phase 1/2 clinical trials to treat melanoma, colorectal cancer, and other solid malignancies; and CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor with an L858R mutation in non-small cell lung cancer. It has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; Betta Pharmaceuticals, Co., Ltd.; Merck KGaA; and Merck Sharp & Dohme, LLC, as well as Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Compare CCCC to Peers and Sector
Metrics to compare | CCCC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCCCCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | −6.4x | −0.6x | |
PEG Ratio | 0.74 | −0.02 | 0.00 | |
Price/Book | 1.3x | 2.4x | 2.6x | |
Price / LTM Sales | 6.5x | 20.0x | 3.2x | |
Upside (Analyst Target) | 246.5% | 42.9% | 41.8% | |
Fair Value Upside | Unlock | 1.0% | 5.1% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.14
(+451.63% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.44 / -0.41
Revenue / Forecast
11.23M / 6.13M
People Also Watch
FAQ
What Is the C4 (CCCC) Share Price Today?
The live C4 share price today is 2.02
What Stock Exchange Does C4 (CCCC) Trade On?
C4 is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for C4?
The stock symbol (also called a 'ticker') for C4 is "CCCC."
What Is the Current C4 Market Cap?
As of today, C4 market capitalisation is 195.77M.
What Is C4's (CCCC) Earnings Per Share (TTM)?
The C4 EPS is currently -1.67 (Trailing Twelve Months).
When Is the Next C4 Earnings Date?
C4's next earnings report will be released on 19 Feb 2026.
Is CCCC a Buy or Sell From a Technical Analyst Perspective?
Based on today's C4 moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has C4 Stock Split?
C4 has split 0 times. (See the CCCC stock split history page for full effective split date and price information.)
How Many Employees Does C4 Have?
C4 has 110 employees.
What is the current trading status of C4 (CCCC)?
As of 24 Dec 2025, C4 (CCCC) is trading at a price of 2.02, with a previous close of 2.02. The stock has fluctuated within a day range of 1.93 to 2.07, while its 52-week range spans from 1.09 to 4.26.
What Is C4 (CCCC) Price Target According to Analysts?
The average 12-month price target for C4 is USD11.14286, with a high estimate of USD29 and a low estimate of USD5. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +451.63% Upside potential.
What Is the CCCC After Hours Price?
CCCC's last after hours stock price is 1.98, the stock has decreased by -0.04, or -1.98%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.